These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11905586)

  • 21. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein(a) is a potential coronary risk factor.
    Fujino A; Watanabe T; Kunii H; Yamaguchi N; Yoshinari K; Watanabe Y; Mutou M; Ishikawa S; Ogyuu A; Ashikawa K; Maruyama Y
    Jpn Circ J; 2000 Jan; 64(1):51-6. PubMed ID: 10651207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
    Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) and coronary heart disease.
    Rodriguez CR; Seman LJ; Ordovas JM; Jenner J; Genest MS; Wilson PW; Schaefer EJ
    Chem Phys Lipids; 1994 Jan; 67-68():389-98. PubMed ID: 8187239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial.
    Evans RW; Shpilberg O; Shaten BJ; Ali S; Kamboh MI; Kuller LH
    J Clin Epidemiol; 2001 Jan; 54(1):51-7. PubMed ID: 11165468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
    Peros E; Geroldi D; D'Angelo A; Falcone C; Montagna L; Carabela M; Emanuele E
    Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study.
    Chu NF; Makowski L; Chang JB; Wang DJ; Liou SH; Shieh SM
    Eur J Epidemiol; 2000 Jan; 16(1):5-12. PubMed ID: 10780336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
    Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
    Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.
    Lamon-Fava S; Marcovina SM; Albers JJ; Kennedy H; DeLuca C; White CC; Cupples LA; McNamara JR; Seman LJ; Bongard V; Schaefer EJ
    J Lipid Res; 2011 Jun; 52(6):1181-1187. PubMed ID: 21478162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.
    Kark JD; Sandholzer C; Friedlander Y; Utermann G
    Atherosclerosis; 1993 Jan; 98(2):139-51. PubMed ID: 8457257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.
    Nenseter MS; Lindvig HW; Ueland T; Langslet G; Ose L; Holven KB; Retterstøl K
    Atherosclerosis; 2011 Jun; 216(2):426-32. PubMed ID: 21376325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH; Fortmann SP; Marcovina SM
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
    Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
    Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.
    Genest J; McNamara JR; Ordovas JM; Jenner JL; Silberman SR; Anderson KM; Wilson PW; Salem DN; Schaefer EJ
    J Am Coll Cardiol; 1992 Mar; 19(4):792-802. PubMed ID: 1531990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men.
    Sigurdsson G; Baldursdottir A; Sigvaldason H; Agnarsson U; Thorgeirsson G; Sigfusson N
    Am J Cardiol; 1992 May; 69(16):1251-4. PubMed ID: 1585854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.